Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
Authors
Keywords
-
Journal
EUROPEAN JOURNAL OF HEART FAILURE
Volume 12, Issue 9, Pages 943-950
Publisher
Wiley
Online
2010-07-04
DOI
10.1093/eurjhf/hfq099
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: Implications for clinical studies
- (2009) Joyce J.C. Kroot et al. ANALYTICAL BIOCHEMISTRY
- Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells
- (2009) T. Tanno et al. BLOOD
- High-sensitive radioimmunoassay for human serum hepcidin
- (2009) Nicolai Grebenchtchikov et al. BRITISH JOURNAL OF HAEMATOLOGY
- Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
- (2009) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy
- (2009) G. Weiss et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
- (2009) Damien R. Ashby et al. KIDNEY INTERNATIONAL
- Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
- (2009) Stefan D. Anker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immunoassay for human serum hepcidin
- (2008) T. Ganz et al. BLOOD
- Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBP
- (2008) J. P. Pinto et al. BLOOD
- Erythropoietin in cancer-related anemia
- (2008) Martin H Fenner et al. CURRENT OPINION IN ONCOLOGY
- Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume
- (2008) C. Adlbrecht et al. EUROPEAN HEART JOURNAL
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008‡
- (2008) Kenneth Dickstein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Hepcidin: from discovery to differential diagnosis
- (2008) E. H.J.M. Kemna et al. HAEMATOLOGICA
- Cardiorenal Syndrome
- (2008) Claudio Ronco et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
- (2008) Lynda A. Szczech et al. KIDNEY INTERNATIONAL
- Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease?
- (2008) D. W. Swinkels et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Advances in Quantitative Hepcidin Measurements by Time-of-Flight Mass Spectrometry
- (2008) Dorine W. Swinkels et al. PLoS One
- Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
- (2007) Karien van der Putten et al. Nature clinical practice. Nephrology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started